The authors report five pediatric patients with acute lymphoblastic leukemia (ALL) in whom symptomatic aseptic osteonecrosis developed on therapy. All patients had been on treatment with a modified BFM protocol and developed osteonecrosis in the maintenance phase of the protocol. The avascular necro
Familial microcephaly with normal intelligence in a patient with acute lymphoblastic leukemia
โ Scribed by D. Heney; R. Mueller; G. Turner; G. Karbani; J. Cadranel; I. J. Lewis; C. C. Bailey
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 369 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
The authors describe a family with two children with microcephaly and normal intelligence, in which acute lymphoblastic leukemia developed in one of the siblings. An autosomal recessive pattern of inheritance is suggested by the pedigree. This is consistent with the literature, which the authors reviewed. All of the patients have similar phenotypic features, with some demonstrating chromosomal instability. It is important to recognize this syndrome because of the increased risk of lymphoreticular malignancy.
๐ SIMILAR VOLUMES
## Background: Loss of heterozygosity (loh) at the atm gene (mutated in ataxia telangiectasia [at] patients) and atm protein deficiency occur in 14% and 34%, respectively, of patients with chronic lymphocytic leukemia (cll). atm protein deficiency also is associated with aggressive disease and wors
To prevent heat illnesses, a high index of suspicion should be maintained during a heat wave or while using unacclimatized workers in heavy labor. Employers should measure wet bulb globe temperature index (which correlates with deep body temperature) and plan work schedules within permissible thresh
Twenty-four pediatric patients with acute lymphoblastic leukemia (ALL) on maintenance therapy were evaluated for their compliance with taking their prescribed doses of oral mercaptopurine (6-MP). Procedure and Results. We utilized the Medication Event Monitoring System (MEMS; Aprex Corporation, Fre